Building on the success during the COVID-19 pandemic, independent community pharmacies are taking steps to enhance their readiness for future public health emergencies.
AAM said that by including drugs with generics and biosimilars in development in the 15 drugs selected for negotiation, CMS highlights a central flaw in the IRA price setting scheme.